Skip to main content

WVa Opioid Lawsuit To Go For Trial in April 2022

WVa Opioid Lawsuit To Go For Trial in April 2022

WVa Opioid Lawsuit To Go For Trial in April 2022

Introduction

West Virginia's lawsuit against several drugmakers alleging the manufacturers of misguiding information about the painkiller drugs opioid will go to trial next April, as indicated by the state's attorney general.

The lawsuit alleges that Johnson & Johnson and its subsidiary Janssen Pharmaceuticals Inc. and Endo Health Solutions Inc., along with Teva Pharmaceuticals Inc., caused a public nuisance by violating the state Consumer Credit and Protection Act.

Attorney General Patrick Morrisey claims that the companies deceived the prescribers by engaging in strategic campaigns to promote the products. The manufacturers' strategies eventually resulted in substance abuse in West Virginia, as opioids became the common cure for chronic pain.

The attorney general accused Teva of disguised marketing of opioids as the company guided the doctors to prescribe opioids without disclosing the risks of addiction. The manufacturer even got support from third-party advocates and professional associations for the same.

Johnson & Johnson (J&J) is also accused of refraining the side effects of opioids from the patients by distributing education guides that included misleading information that opioids are not addictive. Another opioid manufacturer, Endo, is also accused of reintroducing a 1960's drug with a change in color and name.

In 2019, McKesson Corp. and Cardinal Health Inc. made a settlement of $37 million and $20 million, respectively, with West Virginia in similar lawsuits. Earlier in 2017, AmerisourceBergen Drug Co. also settled $16 million for fueling the opioid epidemic in the state.

The rate of drug overdose deaths is higher in West Virginia as compared to other states in the nation.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Purdue, Sacklers Agree to New $7.4B Opioid Settlement

Categories: Opioids

All 50 U.S. states, along with the District of Columbia and U.S. territories, have agreed to a $7.4 billion settlement with Purdue Pharma, the manufacturer of OxyContin.

This deal addresses allegations that the company’s aggressive and…

Oregon to Get $66M in Sackler Opioid Settlement

Categories: Opioids

Oregon will gain $66 million as part of a nationwide settlement with the Sackler family and Purdue Pharma, the makers of OxyContin. The funds will be used to expand and…

Study Finds Toxic Metals in E-Cigs and U-Cigs Vapors

Categories: E-Cigarette: JUUL

As health concerns about e-cigarette use escalate, emerging research suggests that a newer class of vaping products—ultrasonic cigarettes or u-cigarettes—may pose even greater risks.

A study published in Environmental Health Perspectives in…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!